BioSpace News Archive

Immunovant, Inc. announced the closing of its business combination with Immunovant Sciences Ltd., a clinical stage biopharmaceutical company developing IMVT-1401, a fully human monoclonal antibody that selectively binds to and inhibits the neonatal Fc receptor and is designed to be delivered by subcutaneous injection.

LignaMed, LLC announced published preclinical data demonstrated that lead candidate LGM2605 is highly efficacious in producing a protective effect on Airway Hyperreactivity in a model of Th2-low asthma, a subtype of glucocorticoid resistant asthma.

Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced that it has completed a $6M investment from its long term Private Investor in the form of a Preferred Equity transaction.

Topline results from the NORSE 1 study of ONS-5010 expected to be announced in the third quarter of calendar 2020

Encompass Health Corporation announced the appointment of three new independent directors, Greg Carmichael, Patricia Maryland, and Terrance Williams, effective January 1, 2020.

The Center for Prevention at Blue Cross and Blue Shield of Minnesota has awarded nearly $2 million in funding to 15 organizations from across Minnesota as a part of the Health POWER program, and nearly $500,000 to three organizations working towards systems change related to health equity.

Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, appointed Elaine Caughey to the role of chief business officer.

Haptic Virtual Reality Training Platform Creates Immersive Real-world Training Experience and Offers Access to New Technologies

Scientists will have new view into natural cell activity, accelerating drug development

AEEC was a sponsor of the San Diego Supercomputer Center’s (SDSC) fourth annual Data West Technology Forum, held on December 10th and 11th at the Sanford Consortium for Regenerative Medicine.